904 related articles for article (PubMed ID: 23093685)
1. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.
Esposito K; Chiodini P; Colao A; Lenzi A; Giugliano D
Diabetes Care; 2012 Nov; 35(11):2402-11. PubMed ID: 23093685
[TBL] [Abstract][Full Text] [Related]
2. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
Renehan AG; Tyson M; Egger M; Heller RF; Zwahlen M
Lancet; 2008 Feb; 371(9612):569-78. PubMed ID: 18280327
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.
Esposito K; Chiodini P; Capuano A; Bellastella G; Maiorino MI; Rafaniello C; Panagiotakos DB; Giugliano D
Endocrine; 2013 Dec; 44(3):634-47. PubMed ID: 23546613
[TBL] [Abstract][Full Text] [Related]
4. Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis.
Esposito K; Chiodini P; Capuano A; Bellastella G; Maiorino MI; Parretta E; Lenzi A; Giugliano D
J Endocrinol Invest; 2013 Feb; 36(2):132-9. PubMed ID: 23481613
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis.
Esposito K; Chiodini P; Capuano A; Bellastella G; Maiorino MI; Rafaniello C; Giugliano D
Menopause; 2013 Dec; 20(12):1301-9. PubMed ID: 23571527
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.
Shen X; Wang Y; Zhao R; Wan Q; Wu Y; Zhao L; Wu X
Int J Colorectal Dis; 2021 Oct; 36(10):2215-2225. PubMed ID: 34331119
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and cancer: holistic or reductionist?
Esposito K; Capuano A; Giugliano D
Endocrine; 2014 Apr; 45(3):362-4. PubMed ID: 24065310
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and endometrial cancer: a meta-analysis.
Esposito K; Chiodini P; Capuano A; Bellastella G; Maiorino MI; Giugliano D
Endocrine; 2014 Feb; 45(1):28-36. PubMed ID: 23640372
[TBL] [Abstract][Full Text] [Related]
9. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome, obesity and cancer risk.
Belladelli F; Montorsi F; Martini A
Curr Opin Urol; 2022 Nov; 32(6):594-597. PubMed ID: 36081396
[TBL] [Abstract][Full Text] [Related]
11. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
Bi Y; Wang JL; Li ML; Zhou J; Sun XL
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and risk of prostate cancer: a systematic review and meta-analysis.
Motterle G; DE Zorzi L; Zecchini G; Mandato FG; Ferraioli G; Bianco M; Zanovello N
Panminerva Med; 2022 Sep; 64(3):337-343. PubMed ID: 34859640
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of metabolic syndrome in postmenopausal women: A systematic review and meta-analysis in Iran.
Ebtekar F; Dalvand S; Gheshlagh RG
Diabetes Metab Syndr; 2018 Nov; 12(6):955-960. PubMed ID: 29891195
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study.
Agnoli C; Berrino F; Abagnato CA; Muti P; Panico S; Crosignani P; Krogh V
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):41-8. PubMed ID: 19361966
[TBL] [Abstract][Full Text] [Related]
15. The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: A systematic review and meta-analysis.
Yin DT; He H; Yu K; Xie J; Lei M; Ma R; Li H; Wang Y; Liu Z
Int J Surg; 2018 Sep; 57():66-75. PubMed ID: 30081182
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women.
Kabat GC; Kim MY; Peters U; Stefanick M; Hou L; Wactawski-Wende J; Messina C; Shikany JM; Rohan TE
Eur J Cancer Prev; 2012 Jul; 21(4):326-32. PubMed ID: 22044849
[TBL] [Abstract][Full Text] [Related]
17. Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study.
López-Jiménez T; Duarte-Salles T; Plana-Ripoll O; Recalde M; Xavier-Cos F; Puente D
PLoS One; 2022; 17(3):e0264634. PubMed ID: 35245317
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and liver-related events: a systematic review and meta-analysis.
Ren H; Wang J; Gao Y; Yang F; Huang W
BMC Endocr Disord; 2019 Apr; 19(1):40. PubMed ID: 31023282
[TBL] [Abstract][Full Text] [Related]
19. Symposium introduction: metabolic syndrome and the onset of cancer.
Zhou JR; Blackburn GL; Walker WA
Am J Clin Nutr; 2007 Sep; 86(3):s817-9. PubMed ID: 18265474
[TBL] [Abstract][Full Text] [Related]
20. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.
Stocks T; Rapp K; Bjørge T; Manjer J; Ulmer H; Selmer R; Lukanova A; Johansen D; Concin H; Tretli S; Hallmans G; Jonsson H; Stattin P
PLoS Med; 2009 Dec; 6(12):e1000201. PubMed ID: 20027213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
